Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-05

Clinical Trial Update: Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy. [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 studies assessed prophylactic dosing of enoxaparin to prevent venous thromboembolism during pregnancy; results were posted after study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Stanford University | Conditions: Venous Thrombosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-09-05